Are you interested in Bavarian Nordic´s CDMO services or you want to discuss your project with our experts? Please fill in the fields to get in touch with us.
Sr. Director - Head of Sales, CDMO
As innovators and developers of live virus vaccines, we are fully aware of the complexities and risks to getting product to market under the strictest of regulations. Our combination of expertise, state-of-the-art facility and technology, can guide and accelerate your biological therapeutics from pre-clinical to commercial stage and beyond while delivering the highest quality and reliable sterile products that improve the health and quality of life for children and adults.
Any drug development process must proceed through several stages in order to produce a product that is safe, efficacious, and has passed all regulatory requirements. Our scientists will assist you through all stages of CMC development and will help you to determine your testing needs. Our experienced staff can perform the critical tests and studies that are necessary to achieve regulatory approval.
Our virus seed-banking processes and the BSL2 facility we use to manufacture your virus seed stocks are fully GMP compliant and offer high quality, stable and fully traceable starting material for GMP manufacturing of clinical and commercial products.
Our talented people, well thought-through processes and comprehensive, validated equipment have been utilized in our BSL2 classified facility to fulfill numerous drug substance projects for preclinical, clinical and commercial supply.
Today Bavarian Nordic offers fill and finish services using innovative technologies that are specifically designed to protect your biologic’s integrity and optimize yield of costly drug product. With a wealth of experience dealing with biologics, our scientists provide expertise across all areas of parenteral formulation and sterile manufacturing. By 2020 we will also provide large scale manufacturing, lyophilization and an integrated packaging line with serialization in our new fill and finish facility.
We value the importance of product quality and compliance: Our objective is to be sure your product supply does not become the rate-limiting step for its overall development. Working with you from early stages of development to commercial scale/production, we will ensure that your product is of high quality and reaches your patients on time.
Speaking as one biotech company to another, we appreciate the complexities of product development and manufacturing. By expanding our clinical and small scale commercial capabilities to a full commercial fill and finish facility with dedicated customer capacity, we will support you even further in bringing your valued products to your patients.
EVP, COO, Bavarian Nordic
We´re experts working with live viruses and vaccines from discovery to development to manufacturing both for clinical and market supplies. Our reputation as a leading global vaccines provider is built on long-term collaborative relationships with government agencies and top-tier industry partners.
As innovators and developers of live virus vaccines, we’re passionate about tackling diseases that really burden people’s lives. We have vaccines in clinical testing against a variety of advanced cancers and in serious infectious diseases.
We’re invested in bringing our expertise, knowledge and passion to work for you by offering CDMO capabilities and services already today. By 2020 we also have a new large scale fill and finish facility where we can offer expanded BSL2 and lyophilization capacity.
6-7th February 2019
Porte de Versailles - Hall 7.2
Visit us at Stand H59
April 30-May 2nd, 2019
McCormick Place - Chicago, Illinois
Visit us at booth 418
5-7th November 2019
Visit us at booth 121G74
Bavarian Nordic is a global, fully vertically integrated biotechnology company focused on the research, development, manufacturing and marketing of innovative and safer vector-based vaccines against cancer and infectious diseases. Our goal is to improve the health and quality of life for children and adults, focusing on indications for which the unmet medical need is high and for which we can harness the power of the immune system to induce a response.
Headquarter & Manufacturing
3025 Carrington Mill Boulevard
Morrisville NC 27560
Research & Development